Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Diabetes Research and Clinical Practice|November 4, 2017
Assessment of self-management in patients with diabetes using the novel LMC Skills, Confidence and Preparedness Index (SCPI)Ronnie Aronson, Ruth E Brown, Dishay Jiandani, et al.
Diabetes Technology & Therapeutics|November 7, 2019
Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 DiabetesRonnie Aronson, Edward Mahoney, Drilon Saliu, et al.
Clinical Therapeutics|June 25, 2013
Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratingsRonnie Aronson, Michael A Gibney, Kunjal Oza, et al.
Advances in Therapy|August 22, 2014
Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trialsMarkolf Hanefeld, Rachele Berria, Jay Lin, et al.
Lancet (London, England)|July 7, 2014
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trialYves Reznik, Ohad Cohen, Ronnie Aronson, et al.
Diabetes Technology & Therapeutics|July 16, 2020
The Canadian LMC Diabetes Registry: A Profile of the Demographics, Management, and Outcomes of Individuals with Type 1 DiabetesRonnie Aronson, Ruth E Brown, Alexander Abitbol, et al.
Diabetes Technology & Therapeutics|April 17, 2014
OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methodsRonnie Aronson, Ohad Cohen, Ignacio Conget, et al.
Diabetes Research and Clinical Practice|August 26, 2019
Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes studyRuth E Brown, Alexander Abitbol, Harpreet S Bajaj, et al.
Diabetes Care|April 9, 2013
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)Matthew C Riddle, Thomas Forst, Ronnie Aronson, et al.
Diabetes Research and Clinical Practice|January 15, 2019
Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetesMichael C Riddell, Rubin Pooni, Loren Yavelberg, et al.
Pageof 7